Fig. 5From: Management of retinitis pigmentosa by Wharton’s jelly-derived mesenchymal stem cells: prospective analysis of 1-year resultsIncrease in “horizontal ellipsoid zone width” according to study timepoints (T0, T1, T2) in the eye treated with WJ-MSCs (Table 1, patient 26: left eye). a Before application, 2.11 mm. b At 6th month, 2.17 mm. c At 12th month, 2.22 mmBack to article page